Cargando…
Oncogenic secretory clusterin in hepatocellular carcinoma: Expression at early staging and emerging molecular target
Secretory clusterin (sCLU) is associated with hepatocellular carcinoma (HCC) progression by contributing to angiogenesis, chemoresistance, cell survival, and metastasis. However, the sCLU expression at early stage of HCC progression remains to be clarified. In this study, the alteration of sCLU onco...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581031/ https://www.ncbi.nlm.nih.gov/pubmed/28881732 http://dx.doi.org/10.18632/oncotarget.13674 |